149 related articles for article (PubMed ID: 26365874)
21. High-content assays in oncology drug discovery: opportunities and challenges.
Mouchet EH; Simpson PB
IDrugs; 2008 Jun; 11(6):422-7. PubMed ID: 18509783
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells.
Sandoval M; Harris L
Oncology (Williston Park); 2014 Dec; 28(12):1110-1, 1114. PubMed ID: 25510810
[No Abstract] [Full Text] [Related]
23. Target Gene Discovery for Novel Therapeutic Agents in Cancer Treatment.
Tiwari S; Ammerpohl O; Kalthoff H
Methods Mol Biol; 2016; 1381():181-200. PubMed ID: 26667461
[TBL] [Abstract][Full Text] [Related]
24. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
25. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
Roukos DH
Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
[No Abstract] [Full Text] [Related]
26. Discovery and development of aurora kinase inhibitors as anticancer agents.
Pollard JR; Mortimore M
J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
[No Abstract] [Full Text] [Related]
27. Phase 0 trials for anticancer drug development.
Nat Rev Drug Discov; 2009 Jun; 8(6):442. PubMed ID: 19483703
[No Abstract] [Full Text] [Related]
28. Objective assessment of cancer genes for drug discovery.
Patel MN; Halling-Brown MD; Tym JE; Workman P; Al-Lazikani B
Nat Rev Drug Discov; 2013 Jan; 12(1):35-50. PubMed ID: 23274470
[TBL] [Abstract][Full Text] [Related]
29. Oncology drug discovery: planning a turnaround.
Toniatti C; Jones P; Graham H; Pagliara B; Draetta G
Cancer Discov; 2014 Apr; 4(4):397-404. PubMed ID: 24706659
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells: the development of new cancer therapeutics.
Scatena R; Bottoni P; Pontoglio A; Giardina B
Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells: getting to the root of cancer.
Azvolinsky A
J Natl Cancer Inst; 2012 Jun; 104(12):893-5. PubMed ID: 22715190
[No Abstract] [Full Text] [Related]
32. Targeting survivin in cancer: the cell-signalling perspective.
Kanwar JR; Kamalapuram SK; Kanwar RK
Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
[TBL] [Abstract][Full Text] [Related]
33. Inadequacy of tissue microarrays for the immunohistochemical detection of cancer stem cells in solid tumors: a viewpoint.
Cantile M; Collina F; Scognamiglio G; Di Bonito M; Franco R; Botti G
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1139-41. PubMed ID: 24099570
[No Abstract] [Full Text] [Related]
34. High-throughput screening finds potential killer of cancer stem cells.
Rowan K
J Natl Cancer Inst; 2009 Nov; 101(21):1438-9. PubMed ID: 19828869
[No Abstract] [Full Text] [Related]
35. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
36. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
Futamura Y; Kawatani M; Kazami S; Tanaka K; Muroi M; Shimizu T; Tomita K; Watanabe N; Osada H
Chem Biol; 2012 Dec; 19(12):1620-30. PubMed ID: 23261605
[TBL] [Abstract][Full Text] [Related]
37. Targeting cancer stem cells to suppress acquired chemotherapy resistance.
Vidal SJ; Rodriguez-Bravo V; Galsky M; Cordon-Cardo C; Domingo-Domenech J
Oncogene; 2014 Sep; 33(36):4451-63. PubMed ID: 24096485
[TBL] [Abstract][Full Text] [Related]
38. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
39. Q&A: John Dick on stem cells and cancer.
Dick J
Cancer Discov; 2013 Feb; 3(2):131. PubMed ID: 23400460
[No Abstract] [Full Text] [Related]
40. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
